505 related articles for article (PubMed ID: 23079005)
1. Axial spondyloarthritis: thoughts about nomenclature and treatment targets.
Braun J
Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S132-5. PubMed ID: 23079005
[TBL] [Abstract][Full Text] [Related]
2. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
Malaviya AN; Kalyani A; Rawat R; Gogia SB
Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
[TBL] [Abstract][Full Text] [Related]
3. [Spondyloarthritides].
Rudwaleit M
Internist (Berl); 2017 Jul; 58(7):687-701. PubMed ID: 28593426
[TBL] [Abstract][Full Text] [Related]
4. Management of Axial Spondyloarthritis - Insights into Upadacitinib.
Braun J; Kiltz U; Baraliakos X
Drug Des Devel Ther; 2022; 16():3609-3620. PubMed ID: 36268520
[TBL] [Abstract][Full Text] [Related]
5. One year in review 2018: axial spondyloarthritis.
Carli L; Calabresi E; Governato G; Braun J
Clin Exp Rheumatol; 2019; 37(6):889-898. PubMed ID: 31796161
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Non-radiographic Axial Spondyloarthritis and Ankylosing Spondyltis from a Single Rheumatology Hospital in Morocco.
Akasbi N; Nihad S; Sofia Z; Khadija EK; Taoufik H
Curr Rheumatol Rev; 2020; 16(3):240-244. PubMed ID: 30806321
[TBL] [Abstract][Full Text] [Related]
7. Therapy of spondyloarthritides.
Braun J
Adv Exp Med Biol; 2009; 649():133-47. PubMed ID: 19731626
[TBL] [Abstract][Full Text] [Related]
8. Optimisation of rheumatology assessments - the actual situation in axial spondyloarthritis including ankylosing spondylitis.
Braun J; Kiltz U; Baraliakos X; van der Heijde D
Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-96-104. PubMed ID: 25365096
[TBL] [Abstract][Full Text] [Related]
9. The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis.
Deodhar A; Strand V; Kay J; Braun J
Ann Rheum Dis; 2016 May; 75(5):791-4. PubMed ID: 26768406
[TBL] [Abstract][Full Text] [Related]
10. New evidence on the management of spondyloarthritis.
Sieper J; Poddubnyy D
Nat Rev Rheumatol; 2016 May; 12(5):282-95. PubMed ID: 27052489
[TBL] [Abstract][Full Text] [Related]
11. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.
Rudwaleit M; van der Heijde D; Landewé R; Akkoc N; Brandt J; Chou CT; Dougados M; Huang F; Gu J; Kirazli Y; Van den Bosch F; Olivieri I; Roussou E; Scarpato S; Sørensen IJ; Valle-Oñate R; Weber U; Wei J; Sieper J
Ann Rheum Dis; 2011 Jan; 70(1):25-31. PubMed ID: 21109520
[TBL] [Abstract][Full Text] [Related]
12. Acute anterior uveitis and other extra-articular manifestations of spondyloarthritis.
Mitulescu TC; Popescu C; Naie A; Predeţeanu D; Popescu V; Alexandrescu C; Voinea LM
J Med Life; 2015; 8(3):319-25. PubMed ID: 26351533
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.
Ciurea A; Scherer A; Exer P; Bernhard J; Dudler J; Beyeler B; Kissling R; Stekhoven D; Rufibach K; Tamborrini G; Weiss B; Müller R; Nissen MJ; Michel BA; van der Heijde D; Dougados M; Boonen A; Weber U;
Arthritis Rheum; 2013 Dec; 65(12):3096-106. PubMed ID: 23983141
[TBL] [Abstract][Full Text] [Related]
14. Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials.
Toussirot E; Vauchy C; Binda D; Michel F
Drug Des Devel Ther; 2016; 10():2087-94. PubMed ID: 27445459
[TBL] [Abstract][Full Text] [Related]
15. Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment.
Paramarta JE; De Rycke L; Ambarus CA; Tak PP; Baeten D
Rheumatology (Oxford); 2013 Oct; 52(10):1873-8. PubMed ID: 23861532
[TBL] [Abstract][Full Text] [Related]
16. Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial.
Song IH; Weiß A; Hermann KG; Haibel H; Althoff CE; Poddubnyy D; Listing J; Lange E; Freundlich B; Rudwaleit M; Sieper J
Ann Rheum Dis; 2013 Jun; 72(6):823-5. PubMed ID: 23172749
[TBL] [Abstract][Full Text] [Related]
17. [Ocular involvement in spondylarthritis--new mechanisms, new therapies].
Itulescu TC; Alexandrescu C; Voinea LM
Oftalmologia; 2014; 58(1):27-35. PubMed ID: 25145120
[TBL] [Abstract][Full Text] [Related]
18. Can we reduce the dosage of biologics in spondyloarthritis?
Olivieri I; D'Angelo S; Padula A; Leccese P; Nigro A; Palazzi C
Autoimmun Rev; 2013 May; 12(7):691-3. PubMed ID: 22940233
[TBL] [Abstract][Full Text] [Related]
19. The concept of spondyloarthritis: where are we now?
Garg N; van den Bosch F; Deodhar A
Best Pract Res Clin Rheumatol; 2014 Oct; 28(5):663-72. PubMed ID: 25488776
[TBL] [Abstract][Full Text] [Related]
20. Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents.
Gao X; Wendling D; Botteman MF; Carter JA; Rao S; Cifaldi M
J Med Econ; 2012; 15(6):1054-63. PubMed ID: 22563743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
